Wockhardt, a giant pharmaceutical company, has announced the launch of generic version of top selling heart burn drug Protonix. Protonix is manufactured and marketed by Pfizer Inc all over world.
USA FDA has given approval to the generic of Protonix called Pantoprazole. Application was filed by Wockhardt to seek permission to manufacture delayed release tablets of Protonix. Company will be making 40mg and 20mg dosage delayed tablets.
Protonix is used to treat acidity, gastrointestinal tract infection (stomach ulcers). It is patent protected until 2011. Pharmaceutical companies can seek approval before the patent expiry but they can not manufacture befire the date.
Protonix is the class of drug known as proton pump inhibitor. It inhibits action of proton pump and thereby limits acid production in stomach. Delayed release tablets of protonix will provide relief for longer than normal tablets.
Wackhardt is focused to provide generic version of brand drug on the day patent expires as it is important to keep up return optimal value.
The company is eying to maximize its already growing market share in USA. This is possible if it becomes the first company to provide generic replacement of brand drug.
To ensure security concerns, generic drugs will manufactured at USA FDA certified plant.
USA FDA has given approval to the generic of Protonix called Pantoprazole. Application was filed by Wockhardt to seek permission to manufacture delayed release tablets of Protonix. Company will be making 40mg and 20mg dosage delayed tablets.
Protonix is used to treat acidity, gastrointestinal tract infection (stomach ulcers). It is patent protected until 2011. Pharmaceutical companies can seek approval before the patent expiry but they can not manufacture befire the date.
Protonix is the class of drug known as proton pump inhibitor. It inhibits action of proton pump and thereby limits acid production in stomach. Delayed release tablets of protonix will provide relief for longer than normal tablets.
Wackhardt is focused to provide generic version of brand drug on the day patent expires as it is important to keep up return optimal value.
The company is eying to maximize its already growing market share in USA. This is possible if it becomes the first company to provide generic replacement of brand drug.
To ensure security concerns, generic drugs will manufactured at USA FDA certified plant.
No comments:
Post a Comment